Vitestro

Want to work in the cutting edge field of healthcare robotics? We’re hiring in the Netherlands! Another technical service position just opened up. Apply below or reach out to me directly.

Yesterday, a group of colleagues who joined Vitestro over the past few months came together for our New Joiners Day. Seasoned team members presented on different topics, from the technology to how we work, and new joiners got the chance to connect with each other for the first time. A lot of talented people in one room. We're looking forward to what this team builds together! #Vitestro #Aletta #AutonomousPhlebotomy

𝗧𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗽𝗵𝗹𝗲𝗯𝗼𝘁𝗼𝗺𝘆: 𝗮 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗰𝗵𝗼𝗶𝗰𝗲, 𝘄𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲 𝗲𝗺𝗽𝗼𝘄𝗲𝗿𝗺𝗲𝗻𝘁, 𝗮𝗻𝗱 𝗮 𝗻𝗲𝘄 𝗺𝗼𝗱𝗲𝗹 𝗼𝗳 𝗰𝗮𝗿𝗲   That's the vision emerging from the ADOPT trial results, explored in a new feature by The Pathologist   Vitestro’s Chief Medical Officer Luuk Giesen and ADOPT researcher Thijs Van Holten, Clinical Chemist at St. Antonius Ziekenhuis, reflect on what the data revealed about patient acceptance, staff perspectives, and how autonomous robotic phlebotomy can be integrated into real clinical workflows.   The future they describe is one where manual and autonomous robotic phlebotomy operate side by side, giving patients the ability to choose the experience that best meets their needs. Phlebotomy staff transition between traditional blood collection and oversight of automated systems, creating a more diverse and engaging role while helping address the growing workforce challenges.   Read the full conversation: https://lnkd.in/dyAuEBEu   #Vitestro #Aletta #AutonomousPhlebotomy #ARPD    ---------- Disclaimer: Aletta® is CE-certified for clinical use in the European Union. Aletta® is not approved by the FDA and is not available for sale or use in the United States.

Our CEO Toon Overbeeke sat down with Henry Norton on The Crux of MedTech. Toon shares the origin of Vitestro, surprising patient adoption findings, and what it takes to scale a MedTech company from two people to over 100. Worth a listen: https://lnkd.in/dhkFb3x8 #Vitestro #Aletta #ARPD #AutonomousPhlebotomy

𝗩𝗶𝘁𝗲𝘀𝘁𝗿𝗼 𝗔𝗽𝗽𝗼𝗶𝗻𝘁𝘀 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗘𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗘𝗹𝗶𝗮𝗻𝗲 𝗦𝗰𝗵𝘂𝘁𝘁𝗲 𝘁𝗼 𝗶𝘁𝘀 𝗕𝗼𝗮𝗿𝗱 𝗼𝗳 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿𝘀 Vitestro is proud to announce the appointment of Eliane Schutte to its Board of Directors as a non-executive, independent director. Eliane brings more than 25 years of global leadership experience across MedTech and biotech, with deep expertise in product development, clinical strategy, quality assurance, regulatory affairs, and commercialization. As CEO of Xeltis, she has helped strengthen the company’s strategic direction across vascular applications, led major financing and strategic licensing initiatives totaling more than €110 million, and advanced the organization into pivotal clinical trials in preparation for market approvals and commercialization. She joined Xeltis in 2015 as Chief Development Officer, where she led clinical development, product development, and regulatory strategy. Prior to Xeltis, Eliane held senior leadership roles including Vice President of Global Product Development at The Medicines Company, Chief Development Officer at Profibrix, Founder and owner of Signifix, a quality assurance and regulatory affairs (QA/RA) consulting firm, and Vice President of Regulatory Affairs at IsoTis Orthobiologics, a publicly traded company later acquired. Earlier in her career, she held quality engineering roles at Medtronic. Eliane’s extensive experience in quality assurance, regulatory affairs, clinical development, and scaling innovative healthcare technologies from development through commercialization further strengthens Vitestro’s Board as we continue advancing autonomous robotic phlebotomy and preparing for broader market expansion. “We are excited to welcome Eliane to the Vitestro Board of Directors,” said Toon Overbeeke, CEO and Co-founder of Vitestro. “Her deep expertise in clinical development, regulatory strategy, and the commercialization of breakthrough medical technologies will be invaluable as we continue advancing the Aletta® Autonomous Robotic Phlebotomy Device™ (ARPD™) across Europe and ultimately the United States.” “Vitestro is pioneering an important new category in laboratory automation at a time when healthcare systems around the world are facing increasing operational and staffing pressures,” said Eliane Schutte. “I look forward to working alongside the Board and leadership team as the company advances autonomous robotic phlebotomy and continues building the clinical, regulatory, and commercial foundation for long term global growth.” We look forward to the strategic insights and guidance Eliane will provide alongside our Board and leadership team as Vitestro continues its mission to help enable the future of total laboratory workflow automation, help mitigate the global staffing shortage, and improve the patient experience through innovation. #Vitestro #Xeltis #LaboratoryAutomation #MedicalRobotics #HealthcareInnovation #Diagnostics #Automation #AI #MedTech

Great to have been part of the ALDA conference in Boston last week!   Our CEO Toon Overbeeke introduced Vitestro and Aletta® to the ALDA community, a gathering where diagnostics leaders and life science executives come together to discuss what's next for the field.   Thank you to the Analytical, Life Science & Diagnostics Association (ALDA) community for the warm welcome! We look forward to staying engaged.                                                     #Vitestro #Aletta #ARPD #AutonomousPhlebotomy #ALDA

We are grateful to LSI for shining a light on the work the Vitestro team is doing to bring autonomous phlebotomy into clinical practice! Read the full Innovator Spotlight in the post below. #Vitestro #Aletta #AutonomousPhlebotomy

Vi er på vej til Klinisk Kemi i Linköping! Kom og oplev Aletta® live – se robotten i aktion og få en førstehåndsoplevelse af, hvordan autonom blodprøvetagning fungerer! Vitestro præsenterer vores publicerede studie fra Clinical Chemistry – med first-hand erfaringer og kliniske resultater fra Nederlandene. 📅 7. maj, kl. 8:00–8:45 🎤 Michael Fouraux, PhD (Result Laboratorium, Dordrecht) & Luuk Giesen, MD (CMO, Vitestro) Automatiseret blodprøvetagning er ikke fremtid – det er nu. Vi glæder os til at møde jer! 🙌 👉 www.vitestro.com #KliniskKemi #Vitestro #Aletta #Blodprøvetagning #MedTech #Robotic

We had a great time at Inspire Health & Care 2026 in Ghent! It was great connecting with Belgian healthcare professionals and showcasing Aletta® to a large number of visitors. Big thanks to Inspire Health & Care team for organizing this event! Missed us and curious about Aletta®? Contact us at: https://lnkd.in/eYFV_WPZ #IHC26 #Aletta #Vitestro #AutonomousPhlebotomy

𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗶𝗻𝗴 𝗼𝘂𝗿 𝗹𝗮𝗻𝗱𝗺𝗮𝗿𝗸 𝗽𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗖𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆   We are incredibly proud to share that the results of our multicenter ADOPT clinical trial have been published in Clinical Chemistry, representing the first peer-reviewed multicenter study of a fully autonomous robotic system performing diagnostic venous blood draws.   A huge thank you to our study partners at Amsterdam UMC, St. Antonius Ziekenhuis, OLVG Lab BV, Result Laboratorium, and Mayo Clinic.   Key takeaways: 📌94.5% overall first-stick success rate, with strong results across key subgroups including elderly patients, patients with obesity, and those with self-reported difficult venous access (see publication for full details) 📌0.3% hemolysis rate and 0.6% adverse event rate (all mild), both below published rates for manual phlebotomy 📌 90% of patients reported less or similar pain vs. a manual draw, and 82% would prefer Aletta® or had no preference for their next visit   A major step toward establishing autonomous phlebotomy as the new standard for diagnostic blood collection.   Read the full paper: https://lnkd.in/es95ASXP   #Vitestro #Aletta #Phlebotomy #AutomatedPhlebotomy #AutonomousRoboticPhlebotomyDevice #ARPD   Note: this study evaluated an investigational version of the device, and the results have not been reviewed by European regulatory authorities or the FDA